comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 01:02:43 - browse：2771

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Pence says 'crackpot lawyers' told Trump what he wanted to hear

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Physician groups backed by private equity giant lobby on mergers

What to expect as Trump is arraigned on his Jan 6. indictment

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

NIH launches clinical trials and new research office for long Covid

Biden tests positive for Covid

focus

comprehensive

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Key House panel plots a new health care package

Malaria cases in Florida and Texas: Here’s what you need to know

Mitch McConnell episode has important public health takeaway

Trump demands the U.S. pay no more for drugs than other countries … again

AI can’t replace a physician’s gut feeling

Trump demands the U.S. pay no more for drugs than other countries … again

FDA approves RSV monoclonal antibody for infants, toddlers

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Group opposing PBM reform sets lobbying record

leisure time

AI can’t replace a physician’s gut feeling

NIH launches clinical trials and new research office for long Covid

Medicare has a new plan to address drug shortages

Medicare has a new plan to address drug shortages

Doctors find melanoma drugs effective against rare brain cancer

Amazon expands telehealth clinic nationwide

focus

focus

focus

Wikipedia